Acadia Pharmaceuticals Focuses on Next-Gen Neuroscience

Catherine Owen Adams, Acadia Pharmaceuticals CEO speaks with Tim Stenovec and Emily Graffeo about Acadia delivering first & only FDA-approved Parkinson’s drug. (Source: Bloomberg)